Carl L. G. Hansen
CIK: 0001834412
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AbCellera Biologics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 1, 2026ABCL
AbCellera Biologics Inc.
Award(A)DirectShare option (right to buy)
2.1M shares- - Jan 1, 2025ABCL
AbCellera Biologics Inc.
Award(A)DirectShare option (right to buy)
2.7M shares- - Nov 25, 2024ABCL
AbCellera Biologics Inc.
Exercise(M)Direct56.1K shares at avg. $2.70$152K - Sep 20, 2024ABCL
AbCellera Biologics Inc.
Exercise(M)Direct56.1K shares at avg. $2.70$152K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 1, 2026 | ABCL AbCellera Biologics Inc. | Award(A) Share option (right to buy) | 2,106,505 | - | - | Direct |
| Jan 1, 2025 | ABCL AbCellera Biologics Inc. | Award(A) Share option (right to buy) | 2,730,109 | - | - | Direct |
| Nov 25, 2024 | ABCL AbCellera Biologics Inc. | Exercise(M) | 56,125 | $2.70 | $151,538 | Direct |
| Sep 20, 2024 | ABCL AbCellera Biologics Inc. | Exercise(M) | 56,125 | $2.70 | $151,538 | Direct |
1-4 of 4 transactions
About Hansen Carl L. G.
Hansen Carl L. G. (SEC CIK 0001834412) files insider reports with the SEC as Chief Executive Officer of AbCellera Biologics Inc. (ABCL).
Signal8 holds 4 ownership filings by Hansen Carl L. G., all Form 4s, filed between Sep 24, 2024 and Jan 5, 2026. Those filings report 4 transactions, from Sep 20, 2024 to Jan 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hansen Carl L. G.'s filings is in VANCOUVER, A1.
Recent filings by Hansen Carl L. G.
Other insiders filing for AbCellera Biologics Inc. (ABCL)
- Hayden Michael R, Director
- Montalbano John S., Director
- Booth Andrew, Chief Financial Officer
- Seely Lynn, Director
- Sandor Victor, Director
- Quake Stephen, Director